Search

everythinglearnresearchcommunity

for

Search:↓

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Dihydrotestosterone (DHT) and its active metabolites play a key role in various diseases, and the development of 5α-reductase inhibitors can help treat these conditions.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Congenital adrenal hyperplasia may be linked to adrenal myelolipoma.

Muscles can make their own androgens, which may help muscle growth.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

Finasteride almost fully depletes allopregnanolone in rat brains and enhances 20α-DHP, but doesn't change 3α-DHP levels.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Androgens and estrogens are crucial for male reproductive health, affecting hormone levels and tissue function.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

Dutasteride did not change rat spermatogenesis or oxidative stress but needs more research.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

The method effectively measures drug impact on DHT levels in prostate treatments.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.